Nearly half a million people are diagnosed and treated for Lyme disease in the U.S. every year, and Pennsylvania is a hot bed ...
ROANOKE, Va. (WDBJ) - Pfizer said it plans to seek regulatory approval of a new vaccine for Lyme disease. Vaccines for Lyme ...
Technical indicators for Pfizer and GSK have turned bullish.
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...
There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot because of a lack of ...
Good news has been scarce for this beaten-down drugmaker.
Up until recently, the stock has been a chronic underperformer.
Pfizer went from Bay Area player to dropout. Now its remaining local employees won't have an office to call home.
Pfizer and Valneva have blamed “fewer than anticipated” Lyme disease cases for the failure of their phase 3 trial to hit its ...
The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...
TrumpRx/MFN pricing risks could pressure margins despite 9.3x fwd P/E, 6.27% dividend and pipeline gains. Read the latest ...
If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results